(Q33509648)

27 July 2017

title

DNA damage induced by cis- and carboplatin as indicator for in vitro sensitivity of ovarian carcinoma cells (English)

1 reference

27 July 2017

0 references

1 reference

1 reference

Florian T Unger

1

1 reference

27 July 2017

Hermann A Klasen

2

1 reference

27 July 2017

Garri Tchartchian

3

1 reference

27 July 2017

Rudy L de Wilde

4

1 reference

27 July 2017

Irene Witte

5

1 reference

27 July 2017

language of work or name

English

0 references

publication date

10 October 2009

1 reference

27 July 2017

1 reference

27 July 2017

volume

9

1 reference

27 July 2017

page(s)

359

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-9-359

27 July 2017

exact match

0 references

cites work

Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Mechanisms of resistance to cisplatin and carboplatin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Identification of platinum-resistance associated proteins through proteomic analysis of human ovarian cancer cells and their platinum-resistant sublines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Molecular mechanisms of resistance and toxicity associated with platinating agents

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Different accumulation of cisplatin, oxaliplatin and JM216 in sensitive and cisplatin-resistant human cervical tumour cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Cytotoxicity of different platinum (II) analogues to human tumour cell lines in vitro and murine tumour in vivo alone or combined with electroporation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Prediction of individual response to platinum/paclitaxel combination using novel marker genes in ovarian cancers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Gemcitabine in epithelial ovarian cancer treatment: current role and future perspectives

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

The comet assay for DNA damage and repair: principles, applications, and limitations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Increased in vitro cellular drug resistance is related to poor outcome in high-risk childhood acute lymphoblastic leukaemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

The use of the MTT assay to study drug resistance in fresh tumour samples.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Is cisplatin-induced cell death always produced by apoptosis?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

The ability of the Comet assay to discriminate between genotoxins and cytotoxins

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

The contribution of cytotoxicity to DNA-effects in the single cell gel test (comet assay).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Gemcitabine: preclinical pharmacology and mechanisms of action.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Comparison of cisplatin and carboplatin cytotoxicity in human ovarian cancer cell lines using the MTT assay

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-359

Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-359

Expression of glutathione S-transferase pi (GST-pi) in human malignant ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-359

Immunohistochemical analysis of drug resistance-associated proteins in ovarian carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-359

Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-359

Chemosensitivity testing predicts survival in ovarian cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768745

Evaluation of drug interactions in the established FEC regimen in primary cultures of tumour cells from patients

31 October 2018

1 reference

12 December 2020

Further studies on the generation of reactive oxygen species from activated anthracyclines and the relationship to cytotoxic action and cardiotoxic effects

1 reference

12 December 2020

Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)

1 reference

12 December 2020

Detection of DNA-crosslinking agents with the alkaline comet assay

1 reference

12 December 2020

Single cell gel electrophoresis: detection of DNA damage at different levels of sensitivity

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-9-359

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference

27 July 2017

1 reference